Healthcare
Healthcare
Bottomline: Warburg-backed Micro Life's revenue, profit jump but patent feud weighs
Medical devices maker Micro Life Sciences Pvt Ltd recorded a significant jump in its revenue and profit for the financial ......
Healthcare
CVC Capital mulling stake sale in HealthCare Global: report
Private equity firm CVC Capital Partners is considering selling a 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises, ......
Healthcare
TPG-backed firm to absorb Indian drugmaker's contract development biz, go public
An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development ......
Healthcare
Bain Capital-backed Emcure Pharma plans IPO, hires bankers
India's Emcure Pharmaceuticals aims to raise $400-$500 million from an initial public offering planned for next year, two sources said, ......
Healthcare
Nirma to acquire 75% stake in Glenmark Life Sciences for $680 mn
Glenmark Pharmaceuticals Ltd said Thursday it has agreed to sell a 75% stake in its subsidiary Glenmark Life Sciences Ltd ......
Healthcare
Temasek-backed Manipal Health buys controlling stake in AMRI Hospitals
Temasek-backed Manipal Health Enterprises Ltd has acquired an 84% stake in Emami Group’s AMRI Hospitals for around Rs 2,300 crore, ......
Healthcare
TPG-backed Asia Healthcare Holdings acquires nephrology hospital chain
Asia Healthcare Holdings (AHH), which operates Motherhood Hospitals and Nova Fertility Clinics, has struck a deal to pick up a majority stake in a urology and ......
Healthcare
Torrent Pharma in talks with multiple PE players for loan to partially fund Cipla bid
India's Torrent Pharmaceuticals is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion ......
Healthcare
OrbiMed eyes high returns from India portfolio exit move
Healthcare-focused private equity firm OrbiMed, which has sealed one new deal since January after adding two new companies to its portfolio in ......
Healthcare
ChrysCapital-backed Intas Pharma weighs $1-bn bid for Biogen's biosimilars biz
Intas Pharmaceuticals Ltd is preparing a bid for Biogen Inc.’s biosimilar business in a transaction that could be valued at ......